Citadel Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$914M Buy
3,738,200
+665,600
+22% +$155M 0.15% 97
2025
Q4
$636M Sell
3,072,600
-495,100
-14% -$97.9M 0.1% 138
2025
Q3
$662M Sell
3,567,700
-179,000
-5% -$30.7M 0.1% 128
2025
Q2
$572M Sell
3,746,700
-1,254,800
-25% -$193M 0.1% 142
2025
Q1
$829M Buy
5,001,500
+1,206,600
+32% +$189M 0.16% 66
2024
Q4
$549M Sell
3,794,900
-221,700
-6% -$34.4M 0.1% 125
2024
Q3
$651M Buy
4,016,600
+1,370,500
+52% +$218M 0.13% 100
2024
Q2
$387M Sell
2,646,100
-503,200
-16% -$74.8M 0.08% 169
2024
Q1
$498M Sell
3,149,300
-589,600
-16% -$93.8M 0.1% 130
2023
Q4
$586M Buy
3,738,900
+199,800
+6% +$30.6M 0.12% 92
2023
Q3
$551M Sell
3,539,100
-555,400
-14% -$91.6M 0.12% 92
2023
Q2
$678M Sell
4,094,500
-771,000
-16% -$124M 0.14% 64
2023
Q1
$754M Buy
4,865,500
+136,400
+3% +$22M 0.17% 56
2022
Q4
$835M Sell
4,729,100
-520,500
-10% -$89.9M 0.2% 52
2022
Q3
$858M Buy
5,249,600
+1,744,000
+50% +$295M 0.2% 45
2022
Q2
$622M Buy
3,505,600
+875,500
+33% +$156M 0.16% 63
2022
Q1
$466M Sell
2,630,100
-1,730,100
-40% -$294M 0.1% 119
2021
Q4
$746M Buy
4,360,200
+441,300
+11% +$72.2M 0.15% 64
2021
Q3
$633M Buy
3,918,900
+1,071,400
+38% +$183M 0.13% 83
2021
Q2
$469M Buy
2,847,500
+37,300
+1% +$6.18M 0.11% 113
2021
Q1
$462M Buy
2,810,200
+644,700
+30% +$104M 0.11% 98
2020
Q4
$341M Buy
2,165,500
+387,000
+22% +$57.1M 0.09% 133
2020
Q3
$265M Buy
1,778,500
+552,600
+45% +$81.8M 0.08% 133
2020
Q2
$172M Sell
1,225,900
-205,500
-14% -$29.9M 0.06% 218
2020
Q1
$188M Buy
1,431,400
+192,300
+16% +$27.3M 0.08% 148
2019
Q4
$181M Buy
1,239,100
+292,100
+31% +$39.6M 0.08% 194
2019
Q3
$123M Buy
947,000
+324,400
+52% +$42.7M 0.06% 316
2019
Q2
$86.7M Sell
622,600
-66,000
-10% -$9.14M 0.04% 454
2019
Q1
$96.3M Sell
688,600
-303,700
-31% -$40.7M 0.05% 377
2018
Q4
$128M Sell
992,300
-62,100
-6% -$8.66M 0.07% 244
2018
Q3
$146M Buy
1,054,400
+40,900
+4% +$5.44M 0.07% 272
2018
Q2
$123M Buy
1,013,500
+330,600
+48% +$41.2M 0.06% 296
2018
Q1
$87.5M Buy
682,900
+365,200
+115% +$49.4M 0.05% 370
2017
Q4
$44.4M Sell
317,700
-153,900
-33% -$21.4M 0.03% 681
2017
Q3
$61.3M Buy
471,600
+26,900
+6% +$3.57M 0.05% 442
2017
Q2
$58.8M Buy
444,700
+2,300
+0.5% +$293K 0.05% 423
2017
Q1
$55.1M Sell
442,400
-83,600
-16% -$9.99M 0.05% 405
2016
Q4
$60.6M Sell
526,000
-325,600
-38% -$37.6M 0.06% 305
2016
Q3
$101M Buy
851,600
+155,400
+22% +$18.9M 0.1% 162
2016
Q2
$84.4M Buy
696,200
+165,400
+31% +$18.8M 0.09% 175
2016
Q1
$57.4M Buy
530,800
+195,500
+58% +$20.2M 0.07% 249
2015
Q4
$34.4M Sell
335,300
-182,400
-35% -$18.3M 0.04% 559
2015
Q3
$48.3M Sell
517,700
-20,900
-4% -$2.02M 0.05% 458
2015
Q2
$52.5M Buy
538,600
+162,000
+43% +$16.2M 0.05% 474
2015
Q1
$37.9M Buy
376,600
+37,600
+11% +$3.82M 0.04% 616
2014
Q4
$35.4M Buy
339,000
+85,100
+34% +$8.97M 0.03% 645
2014
Q3
$27.1M Buy
253,900
+52,200
+26% +$5.41M 0.03% 737
2014
Q2
$21.1M Sell
201,700
-247,800
-55% -$25M 0.02% 777
2014
Q1
$44.2M Sell
449,500
-306,600
-41% -$28.4M 0.05% 449
2013
Q4
$69.3M Buy
756,100
+322,600
+74% +$29.7M 0.09% 240
2013
Q3
$37.6M Sell
433,500
-182,900
-30% -$16.4M 0.06% 416
2013
Q2
$52.9M Buy
+616,400
New +$52.3M 0.09% 243

Other funds holding JNJ

Citadel Advisors's JNJ Position: Q1 2026 in Review

Citadel Advisors increased its Johnson & Johnson (JNJ) stake by 146% in Q1 2026, buying an estimated $267M and bringing the position to 1,930,976 shares worth $472M. The position accounts for 0.08% of the portfolio, ranked #193.

Citadel Advisors first reported a position in JNJ in Q2 2013 and has held it in 49 quarters since. The position peaked at $480M in Q4 2019. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Citadel Advisors held 1,930,976 shares of Johnson & Johnson worth $472M as of Q1 2026.
  • Citadel Advisors bought 1,146,074 Johnson & Johnson shares in Q1 2026, an estimated $267M.
  • Johnson & Johnson made up 0.08% of Citadel Advisors's portfolio in Q1 2026, its #193 holding.
  • Citadel Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Johnson & Johnson position peaked at $480M in Q4 2019.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.